The good news… SCD is preventable. The key to surviving is to quickly terminate ventricular fibrillation by delivering an electrical shock to the heart, as each minute of delay before defibrillation reduces survival by about 10 percent.
Implantable cardioverter defibrillators (ICDs), designed for patients at high risk for SCD, can detect lethal arrhythmias and deliver an electrical shock to the heart to return it to a normal rhythm. Drug therapy can help prevent arrhythmias, but once an arrhythmia occurs, drugs cannot always convert the heart to a normal rhythm. Still, because some of the most effective drug therapies produce unwanted side affects, patient medication non-compliance remains an unresolved issue for physicians.
“Devices are the future,” stated Raffaele Corbisiero, MD, Director of the Section of Electrophysiology, “and I’ll tell you why. They are 100 percent compliant. If the device is in, then you have sudden cardiac death prevention period,” explained Dr. Corbisiero. “It’s not like a beta-blocker that a patient may forget to take or stop taking because it makes them feel bad. The device is always there.”
Devices have become increasingly popular in recent years, not only because they have been streamlined from the larger, obtrusive contraptions of the past to the high-tech miniature devices used today, but also because they can radically improve a patients quality of life. According to Dr. Corbisiero, the fact that these devices also prevent sudden cardiac death is often a secondary benefit in the eyes of many patients, who simply do not believe they are in any real danger of SCD because it hasn’t happened…yet.
People at risk for SCD include those who have survived a heart attack, or a previous SCD episode, patients with a poor cardiac pump function, patients who have heart failure, or patients who have a family history of SCD. Amazingly, only 20 percent of this population actually has an implanted device. “We know what to do with these patients once we get them here,” said Dr. Corbisiero. “The question is, ‘How do we get them here?’”